Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells

Leuk Lymphoma. 2018 Jul;59(7):1717-1721. doi: 10.1080/10428194.2017.1390237. Epub 2017 Oct 18.

Mark B Geyer^{1

2}, Shwetha H Manjunath³, Andrew G Evans⁴, Jae H Park^{1

2}, Marco L Davila⁵, Corey S Cutler⁶, Xiuyan Wang², Yongzeng Wang⁷, Brigitte Senechal⁷, Isabelle Rivière^{2

7}, Michel Sadelain², Jane L Liesveld⁸, Renier J Brentjens^{1

2}

¹ a Department of Medicine , Memorial Sloan Kettering Cancer Center , New York City , NY , USA.
² b Center for Cell Engineering , Memorial Sloan Kettering Cancer Center , New York City , NY , USA.
³ c Department of Medicine , University of Rochester School of Medicine and Dentistry , Rochester , NY , USA.
⁴ d Department of Pathology and Laboratory Medicine , University of Rochester School of Medicine and Dentistry , Rochester , NY , USA.
⁵ e H. Lee Moffitt Cancer Center and Research Institute , Tampa , FL , USA.
⁶ f Division of Hematologic Malignancies , Dana Farber Cancer Institute , Boston , MA , USA.
⁷ g Michael G. Harris Cell Therapy and Cell Engineering Facility , Memorial Sloan Kettering Cancer Center , New York City , NY , USA.
⁸ h Department of Medicine, Hematology Oncology Division , Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry , Rochester , NY , USA.

No abstract available

Publication types